Advertisement for orthosearch.org.uk
Results 1 - 7 of 7
Results per page:
Applied filters
Content I can access

Include Proceedings
Dates
Year From

Year To
Orthopaedic Proceedings
Vol. 88-B, Issue SUPP_III | Pages 373 - 373
1 Oct 2006
Gargiulo B Menage J Evans H Urban J Caterson B Curtis C Eisenstein S Roberts S
Full Access

Introduction: Autologous chondrocyte implantation is routinely used for the repair of articular cartilage defects. A similar method may be employed to treat degenerate intervertebral discs or other connective tissues. A system in which cells could not only be delivered, but also retained would offer advantages compared to ACI. Such a vehicle would also allow a homogenous distribution of cells throughout the defect and enhance nutrient penetration to the seeded cells.

Methods: Bovine nucleus cells were isolated via enzyme digestion and expanded in number to passage 3. The cells were resuspended in 0.8% alginate and loaded into poly vinyl alcohol (PVA) cubes. These constructs were placed into a solution of calcium chloride to ‘gel’ the alginate. Constructs were cultured in DMEM+10% FBS within 15ml conical tubes rotated at 37°C for up to 28 days. Cell distribution/morphology and proliferation were assessed on H& E and Ki-67 stained sections, respectively. The re-expression of a disc cell phenotype was assessed using toluidine blue staining and immunohistochemistry (with antibodies to collagen types I, II, IIA, VI and X, and to the glycosaminoglycans, chondroitin-4- and -6-sulphate and keratan sulphate. RT-PCR was performed using oligonucleotide primers to collagen types I, II and X, aggrecan, link protein, and small leucine-rich PGs.

Results: H& E staining of 10μm-thick cryosections revealed an even distribution of loaded cells throughout the scaffold at day 1 being maintained through to day 28. Toluidine blue staining revealed the presence of GAGs, increasing with time. Ki-67 revealed approximately 5% of cells were proliferating at all time points. Immunohistochemistry demonstrated the production of collagen types I, II, IIA, VI and X and the glycosaminoglycans, chondroitin-4-, -6 and keratan sulphate. RT-PCR results showed mRNA expression of fibromodulin throughout the experiment, lumican at days 14, 21 and 28. Types II and X collagen were present at days 21 and 28.

Conclusions: Combining 0.8% alginate with PVA retained 100% of the seeded cells and allowed an even distribution of cells throughout the scaffold. The immunohistochemistry and RT-PCR demonstrated that the system allowed the bovine nucleus cells to express phenotypic markers expressed by disc cells in vivo. These preliminary results indicate that the PVA/alginate system could act as a suitable delivery device for cells during autologous repair of the intervertebral disc or other connective tissues such as meniscus.


Orthopaedic Proceedings
Vol. 88-B, Issue SUPP_III | Pages 376 - 377
1 Oct 2006
Patterson A Curtis C Caterson B Edwards D Roberts S van Niekerk L Wade R
Full Access

Introduction: The search continues for ideal markers and methods of monitoring cartilage degeneration. Various cartilage components, whole or fragmented, have been measured in synovial fluids. A common problem in quantitating these markers is often the unknown dilution of synovial fluid which can occur in obtaining the samples. In this study we have used urea (ratio in synovial fluid:serum) as a method to correct for the dilution of synovial fluid, and hence to quantify enzyme levels in patients with a spectrum of cartilage degradation, in addition to identifying aggrecan degradation products, many of them for the first time in such samples.

Methods: Forty synovial fluid samples were obtained from 4 groups of individuals (10 in each):

normal,

grade IV chondral damage,

osteochondral defects or

endstage osteoarthritis (OA) of the knee, categorised by the cartilage appearance at arthroscopy.

Levels of matrix metalloproteinases (MMPs) 2 and 3 and the inhibitor, TIMP 1, were measured in the fluids via ELISA assays. Urea levels were measured in blood and synovial fluids and enzymes and their inhibitors were normalized according to the ratio of serum:SF urea, to account for the dilution factor of the SF (Kraus et al 2001). Western blotting was used to identify the presence of aggrecan components (chondroitin-4-sulphate: 2B6 antibody; C-6-S: 3B3 and C-0-S: 1B5; keratan sulphate: BKS-1; the G1 domain: 7D1; interglobular domain: 6B4) and also enzyme degradation products of MMPs (BC14) and aggrecanases (BC3; BC-13).

Results: MMPs 2 and 3 and TIMP 1 were all significantly increased in the synovial fluids from OA patients compared to normals (P< 0.01, 0.001 and 0.01 respectively) and MMP3 was greater in the grade IV chondral and osteochondral defect groups than the normals (P< 0.01). Western blotting demonstrated fragmented aggrecan components with a range of molecular weights. Aggrecanase activity was seen in the OA and grade IV chondral damage groups but not in the osteochondral or normal groups, whereas MMP activity was seen in all 3 groups showing cartilage damage but not in the normals.

Conclusion: Dilution of the synovial fluid, either due to inflammation or joint lavage, is often a problem in quantitating metabolites and markers in joint cavities. This pilot study of a limited number of samples from well characterized patient groups indicates that using urea concentrations in synovial fluid relative to serum provides a mechanism to overcome this. It confirms elevated enzyme activity, both aggrecanase and MMPs, in the joints of patients with degenerate cartilage, compared to normals.


Orthopaedic Proceedings
Vol. 87-B, Issue SUPP_III | Pages 230 - 230
1 Sep 2005
Curtis C Eisenstein S Roberts S Caterson B
Full Access

Introduction: Proteoglycans are found both in the annulus fibrosus and nucleus pulposus of the intervertebral disc and contribute to the hydration of the tissue (aggrecan) and the regulation of matrix assembly (small proteoglycans) [1]. Whilst loss of proteoglycan is the main chemical change in disc degeneration seen in back pain patients, little is known of the events leading to and controlling this loss. In this study the metabolism of the most common proteoglycan, aggrecan, and others including decorin, biglycan, lumican, fibromodulin and versican, together with collagen types I and II were studied in diseased and normal discs.

Methods: Ten discs from patients aged 11–57 years (mean:39±15) with scoliosis (n=1), spondylolisthesis (n=1) and low back pain (n=8), were graded for macroscopic degeneration (Grades 1–4). Three ‘normal’ cadaveric discs from 3 individuals aged 25–27 years (mean 26±1) were also investigated. Disc was either snap-frozen (for RNA isolation) or the proteoglycans extracted with 4M GuHCl. Total RNA was isolated and RT-PCR performed using various oligonucleotide primers. GuHCl-extracted proteoglycan fragments were analysed using Western blotting with a number of antibodies to aggrecan metabolites, collagen metabolites and small leucine-rich proteoglycans.

Results: Intervertebral discs contain a very heterogenous population of proteoglycans demonstrating extensive enzymic degradation, particularly with increasing age and macroscopic degeneration such as is seen in back pain patients. Younger, less degenerate discs contained more biglycan than the older, more degenerate discs. However, the mRNA gene expression analyses demonstrated little cellular activity and potential synthetic response, there was very little expression of particularly in comparison to osteoarthritic cartilage cells which show considerable synthetic capability for all the major matrix components.

Discussion: Our analyses indicate that several biochemical, catabolic and biosynthetic changes occur in disc matrix molecules which are likely to contribute to loss of disc function with ageing and degeneration. The loss of biosynthetic capability of cells is very important in considering the potential of newer therapeutic modalities such as cellular repair and genetic engineering for the treatment of degenerative disc disease.


Orthopaedic Proceedings
Vol. 87-B, Issue SUPP_III | Pages 227 - 227
1 Sep 2005
Rees S Curtis C Dent C Harwood J Caterson B
Full Access

Introduction: Previous studies have demonstrated that exposure of normal bovine and human osteoarthritic cartilage to n-3 polyunsaturated fatty acids (PUFAs) such as those present in fish oils can modulate the expression and activity of the degradative and inflammatory factors that are responsible for cartilage destruction [1,2]. In these studies, supplementation of cartilage explant cultures with n-3 PUFAs resulted in an abrogation of aggrecanase activity as well as mRNA expression of mediators of inflammation. To date, few studies have examined the effect of PUFAs on the metabolism of other tissues within the musculoskeletal system, therefore the present work examines the effect of n-3 PUFA supplementation on tendon metabolism.

Methods: Bovine deep digital flexor tendon explants were obtained from the compressed region of young metacarpophalangeal joints (2-week-old) and supplemented with eicosapentaenoic acid (EPA), as previously described [2]. Release of proteoglycan metabolites was analysed using Western blotting whilst RT-PCR analysis was used to examine the mRNA expression patterns of matrix proteases and inflammatory agents.

Results: Exposure to the n-3 fatty acid, EPA, markedly changed the overall lipid composition profile of the tendon with major changes occurring in the supplemented fatty acid (i.e., EPA), with a concomitant percentage reduction in other polyunsaturated fatty acids. Aggrecanase activity was present in the media from control cultures, as expected [3]. However, supplementation with EPA had no effect on this activity, in contrast to articular cartilage where aggrecanase catabolites were absent from the conditioned media following treatment with n-3 PUFAs [1,2]. mRNA expression for the inflammatory mediators (COX-2, IL-1β, TNF), ADAMTS-5, MMPs and TIMPs was also unchanged following supplementation with EPA, again contrasting with articular cartilage where mRNA expression was abolished.

Discussion: This study demonstrates that exposure of bovine tendon explant cultures to an n-3 PUFA, EPA, had no effect on the mRNA expression or activity of aggrecanases; similarly, expression of the inflammatory mediators was also unaffected. Importantly, within this musculoskeletal tissue, aggrecanases are constitutively active and appear to be involved in normal, everyday turnover of aggrecan, in contrast to non-pathological articular cartilage where aggrecanase-generated metabolites are only detected following treatment with catabolic agents. Similarly, COX-2 mRNA expression is present constitutively within tendons whereas in cartilage it is absent under basal (unstimulated) conditions. These data demonstrate that the incorporation of n-3 PUFAs have a differential effect on the regulatory mechanisms which control gene expression within articular cartilage versus tendon.


Orthopaedic Proceedings
Vol. 87-B, Issue SUPP_II | Pages 169 - 169
1 Apr 2005
Haridas S Curtis C Caterson B Evans R Dent C
Full Access

Aim: To evaluate the functional outcome of patients following intra-osseous suturing for repair of distal biceps tendon ruptures, using the Mayo scoring system. Subsequent analysis of mRNA expression; in the ruptured biceps tendons was performed.

Methods: We operated on 8 patients who had ruptured their biceps tendon. The average ages of the patients were 36 (Range 22–50). The technique involved using intrasosseous suturing via a single anterior skin crease incision. The functional outcome of these patients was scored by using the Mayo elbow performance score. The average follow-up was 7 months. (Range 5–8 months). The tendons were processed for RNA isolation and reverse -transcription – polymerase chain reaction (RT-PCR).

Results: The average subjective assessment (pain and function) of these patients was 63/70 (Range 57–68). The average objective assessment (motion and stability) was 24/30 (Range 22–27). The overall average was 87/100. None of the patients had any complications postoperatively. Our results showed that in the samples of ruptured biceps tendon there was mRNA expression of ECM structural components, especially aggrecan and the small proteoglycans biglycan and decorin. Interestingly, these samples also showed a high expression for the enzymes commonly involved in articular cartilage degradation and turnover, the aggrecanases (ADAMTS-4 and ADAMTS-5) and the matrix metalloproteinases (MMP-3 and MMP-13).

Conclusion: We demonstrated that intrasosseous suturing via a single anterior incision, in-patients with ruptured biceps tendons could provide a good functional outcome. This technique should therefore be considered as one of the surgical options in the management of this condition. We know clinically that patients can rupture their biceps tendon either due to trauma if not due to degenerative conditions. In our study we wanted to know if the subset of patients how ruptured their tendons traumatically had any pre-existing degenerative conditions leading on to the rupture compared to the normal subjects. Interestingly our study has shown that there is mRNA expression of degradative enzymes (aggrecanases and MMPs) in the samples of ruptured biceps tendon. Furthermore, our samples also showed mRNA expression for factors involved in the inflammatory response. In conclusion, mRNA expression of the factors involved in degradation and inflammation may suggest a phenotype that predisposes the biceps tendon to rupture, although further studies are required in order to investigate this.


Orthopaedic Proceedings
Vol. 87-B, Issue SUPP_II | Pages 161 - 161
1 Apr 2005
Haridas* S Curtis C Caterson B Evans R Dent C
Full Access

Aim: To study mRNA expression in ruptured biceps tendon.

Methods: Our study was carried out in the University College of Medicine. We took the biceps tendon of 5 patients who had traumatic ruptures. The age of the patients ranged from 35–53. The tendons were processed for RNA isolation and reverse-transcription-polymerase chain reaction (RT-PCR) carried out in order to investigate the mRNA gene expression in ruptured biceps tendon of extra cellular matrix (ECM) components (e.g. proteoglycans and collagens); ECM degradative components (e.g. aggrecanases and MMPs); inflammatory components (e.g. cytokines and cyclooxygenases); and factors involved in the apoptotic response.

Results: Our results showed that in the samples of ruptured biceps tendon there was a good mRNA expression of ECM structural components, especially aggrecan and the small proteoglycans biglycan and decorin. Interestingly, these samples also showed a high expression for the enzymes commonly involved in articular cartilage degradation and turnover, the aggrecanases (ADAMTS-4 and –5) and the matrix metalloproteinases (MMP-3 and –13). As has been recently reported for Achilles tendon rupture (Cetti et al, 2003), an inflammatory reaction was also observed in these ruptured bicep tendons with expression of the inflammatory cytokines IL-1α and TNFα and the enzyme cyclooxygenase-2.

Conclusion: We know clinically that patients can rupture their biceps tendon either due to trauma if not due to degenerative conditions. In our study we wanted to know if the subset of patients who ruptured their tendons traumatically had any pre-existing degenerative conditions leading on to the rupture compared to the normal subjects. Interestingly our study has shown that there is mRNA expression of degradative enzymes (aggrecanases and MMPs) in the samples of ruptured biceps tendon. Whether these mRNA levels equate to increased enzyme activity of these molecules warrants further investigation. Furthermore, our samples also showed mRNA expression for factors involved in the inflammatory response. In conclusion, mRNA expression of the factors involved in degradation and inflammation may suggest a phenotype that predisposes the bicep tendon to rupture, although further studies are required in order to investigate this further.


Orthopaedic Proceedings
Vol. 87-B, Issue SUPP_I | Pages 36 - 36
1 Mar 2005
Gargiulo B Menage J Curtis C Caterson B Urban J Eisenstein S Roberts S
Full Access

Introduction: Degeneration of the intervertebral disc is characterised by loss of normal cell activity, disc matrix and loss of disc height. There is currently much interest in using cells to effect a biological repair in connective tissues, eg autologous chondrocyte implantation for cartilage repair. Intervertebral discs have a low cell density, with those cells present often being unhealthy and necrotic. Hence, identification of an alternative source of cells for autologous disc repair could be beneficial. Thus we have investigated other types of connective tissue cells to determine if they may be encouraged to undertake a disc cell phenotype.

Materials and Methods: Cells were enzymatically/mechanically extracted from bovine coccygeal discs (annulus and nucleus), skin, bone marrow, periosteum and tendon and the efficiency and proliferation rates assessed. Dermal fibroblasts and bone marrow cells were also grown in a 3D alginate system and compared to disc nucleus pulposus cells for phenotypic expression from 0–28 days. Cell phenotype was assessed via morphology, immunohistochemistry, Western blotting and RT-PCR for mRNA expression.

Results: All cell types could be extracted and proliferated in monolayer, with a flattened and fibroblast-like morphology. Proliferation was slowest for bone marrow cells (4 times slower than nucleus pulposus cells). Cells cultured in alginate became rounded with chondrocyte-like morphology. They remained viable for 4 weeks, but with little replication. Expression or production of proteoglycans, both aggrecan and the small proteoglycans (especially fibromodulin) and collagen types I, II and X was demonstrated for all cell types. There was, however, a difference in the timescale of production between some cell types.

Conclusions: Plasticity of different cell types is well known and the connective tissue cells investigated in this study are capable of responding to the environment in which they are cultured. They can synthesise matrix molecules typically produced by disc cells in vivo and hence warrant further investigation as a potential source of cells for biological repair of the intervertebral disc.